Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
The Canadian drugs and substances strategy: The Government of Canada’s approach to substance use related harms and the overdose crisis - Canada.ca
Apr 19, 2025
legacy-hc-2025-04-21
ID 250571
Later capture
The Canadian drugs and substances strategy: The Government of Canada’s approach to substance use related harms and the overdose crisis - Canada.ca
Jan 1, 2026
hc-20260101
ID 396687
updated1 sections changed
1 sections changed0 added0 removed+0 / -1 linesChange ratio: 0%
--- +++ @@ -503,5 +503,4 @@ Dan Werb , PhD, Executive Director, Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Assistant Professor, University of Toronto Institute of Health Policy, Management and Evaluation, and Assistant Professor, University of California San Diego Division of Infectious Diseases and Global Public Health Page details-Date modified: 2023-11-02